Status:
TERMINATED
Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes
Lead Sponsor:
Pfizer
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This study will evaluate the effect of PF-04136309 in patients with chronic hepatitic C virus infection and abnormal liver enzymes.
Detailed Description
Study recruitment was stopped on Dec 15, 2011 due to difficulty in enrolling the targeted number of patients. Subjects currently enrolled into the study will complete the study as per protocol. There ...
Eligibility Criteria
Inclusion
- Chronic HCV infection
- ALT \>1.5 but \<10 times upper limit of normal
Exclusion
- Decompensated or severe liver disease defined by one or more of the following criteria:
- Prior liver biopsy showing cirrhosis.
- International Normalized Ratio (INR) greater than or equal to 1.5.
- Total bilirubin greater than or equal to 1.5X ULN, or \>2X ULN for unconjugated bilirubin.
- Serum albumin below normal.
- ALT or aspartate aminotransferase (AST) \>10 x ULN.
- Evidence of portal hypertension including splenomegaly, ascites, encephalopathy, and/or esophageal varices.
- Presence of human immunodeficiency virus (HIV).
- Co-infection with hepatitis B virus (HBV).
- Co-infection with Epstein Barr Virus (EBV) and/or Cytomegalovirus (CMV).
Key Trial Info
Start Date :
January 17 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2012
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01226797
Start Date
January 17 2011
End Date
February 9 2012
Last Update
July 27 2023
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong,
Prince of Wales Hospital, Shatin, New Territories,, Hong Kong, Hong Kong, 0
2
The University of Hong Kong,
Hong Kong, Hong Kong, 0
3
Manipal Hospital
Bangalore, Karnataka, India, 560017
4
Seth G. S. Medical College & King Edward Memorial Hospital,
Mumbai, Maharashtra, India, 400 012